LRAT anticorps (N-Term)
Aperçu rapide pour LRAT anticorps (N-Term) (ABIN5516911)
Antigène
Voir toutes LRAT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- MKNPMLEVVS LLLEKLLLIS NFTLFSSGAA GEDKGRNSFY ETSSFHRGDV
-
Homologie
- Human: 100%, Pig: 79%
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human LRAT
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- LRAT (Lecithin Retinol Acyltransferase (Phosphatidylcholine--Retinol O-Acyltransferase) (LRAT))
-
Autre désignation
- LRAT
-
Sujet
-
The protein encoded by this gene localizes to the endoplasmic reticulum, where it catalyzes the esterification of all-trans-retinol into all-trans-retinyl ester. This reaction is an important step in vitamin A metabolism in the visual system. Mutations in this gene have been associated with early-onset severe retinal dystrophy and Leber congenital amaurosis 14. Alternative splicing results in multiple transcript variants.
Alias Symbols: LCA14
Protein Interaction Partner: RBP2, RBP1, LRAT,
Protein Size: 230 -
ID gène
- 9227
-
NCBI Accession
- NM_001301645, NP_004735
-
UniProt
- O95237
Antigène
-